| Literature DB >> 17036368 |
Alireza Foroumadi1, Shahla Mansouri, Saeed Emami, Javad Mirzaei, Maedeh Sorkhi, Nosratollah Saeid-Adeli, Abbas Shafiee.
Abstract
Novel levofloxacin-containing hybrids carrying a 5-(nitroaryl)-1,3,4-thiadiazol-2-yl group were synthesized and evaluated in vitro against Gram-positive and Gram-negative bacteria. Preliminary data indicated that levofloxacin-nitrofuran and levofloxacin-nitroimidazole hybrids have a potent activity against Gram-positive organisms with enhanced anti-staphylococcal activity compared with the parent quinolone (N-desmethyl levofloxacin).Entities:
Mesh:
Substances:
Year: 2006 PMID: 17036368 DOI: 10.1002/ardp.200600108
Source DB: PubMed Journal: Arch Pharm (Weinheim) ISSN: 0365-6233 Impact factor: 3.751